Methicillin-resistant Staphylococcus aureus (MRSA)

also known as oxacillin-resistant Staphylococcus aureus (ORSA), multiple-resistant Staphylococcus aureus, CA-MRSA (community-acquired MRSA) and HA-MRSA (hospital-acquired MRSA), is a biological agent responsible for difficult-to-treat infections in humans. It is a variation of Staphylococcus aureus, a common bacterium, which has evolved the ability to survive treatment with beta-lactam antibiotics, including penicillin and methicillin. The organism is especially troublesome in hospital-acquired (nosocomial) infections. In hospitals, patients may be found who have open wounds and weakened immune systems and who thus are greatly at risk for infection. Hospital staff who do not follow proper sanitary procedures may inadvertently transfer bacterial colonies from patient to patient.

Nova provides efficacy testing of products, pharmaceuticals, and chemicals against MRSA.

Please contact Tamara Trow at ttrow@novatx.com or 936-756-5333 x109 for more information and pricing.